These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31512988)
21. Evaluation of samidorphan, a μ-opioid antagonist, in a drug discrimination assay in rats. Sgro MP; Modlin DL; Deaver DR; Kallman MJ; Todtenkopf MS Drug Dev Res; 2018 Aug; 79(5):234-238. PubMed ID: 30188587 [TBL] [Abstract][Full Text] [Related]
22. Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors. Falcon E; Browne CA; Leon RM; Fleites VC; Sweeney R; Kirby LG; Lucki I Neuropsychopharmacology; 2016 Aug; 41(9):2344-51. PubMed ID: 26979295 [TBL] [Abstract][Full Text] [Related]
23. On the mechanism of antidepressant-like action of berberine chloride. Kulkarni SK; Dhir A Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703 [TBL] [Abstract][Full Text] [Related]
24. Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats. Jastrzębska-Więsek M; Siwek A; Partyka A; Szewczyk B; Sowa-Kućma M; Wasik A; Kołaczkowski M; Wesołowska A Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1079-88. PubMed ID: 26077660 [TBL] [Abstract][Full Text] [Related]
25. Differential responsiveness of inbred strains of rats to antidepressants in the forced swimming test: are Wistar Kyoto rats an animal model of subsensitivity to antidepressants? Lahmame A; Armario A Psychopharmacology (Berl); 1996 Jan; 123(2):191-8. PubMed ID: 8741943 [TBL] [Abstract][Full Text] [Related]
26. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Harkin A; Kelly JP; McNamara M; Connor TJ; Dredge K; Redmond A; Leonard BE Eur J Pharmacol; 1999 Jan; 364(2-3):123-32. PubMed ID: 9932714 [TBL] [Abstract][Full Text] [Related]
27. Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study. Pathak S; Vince B; Kelsh D; Setnik B; Nangia N; DiPetrillo L; Puhl MD; Sun L; Stanford AD; Ehrich E J Clin Pharmacol; 2019 Feb; 59(2):218-228. PubMed ID: 30476361 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of opioid modulation in major depressive disorder. Ehrich E; Turncliff R; Du Y; Leigh-Pemberton R; Fernandez E; Jones R; Fava M Neuropsychopharmacology; 2015 May; 40(6):1448-55. PubMed ID: 25518754 [TBL] [Abstract][Full Text] [Related]
29. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders. Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566 [TBL] [Abstract][Full Text] [Related]
30. Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test. Huang P; Tunis J; Parry C; Tallarida R; Liu-Chen LY Eur J Pharmacol; 2016 Jun; 781():53-9. PubMed ID: 27044434 [TBL] [Abstract][Full Text] [Related]
31. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Nowak G; Szewczyk B; Wieronska JM; Branski P; Palucha A; Pilc A; Sadlik K; Piekoszewski W Brain Res Bull; 2003 Jul; 61(2):159-64. PubMed ID: 12832002 [TBL] [Abstract][Full Text] [Related]
32. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. Mague SD; Pliakas AM; Todtenkopf MS; Tomasiewicz HC; Zhang Y; Stevens WC; Jones RM; Portoghese PS; Carlezon WA J Pharmacol Exp Ther; 2003 Apr; 305(1):323-30. PubMed ID: 12649385 [TBL] [Abstract][Full Text] [Related]
33. Salvindolin elicits opioid system-mediated antinociceptive and antidepressant-like activities. Keasling AW; Pandey P; Doerksen RJ; Pedrino GR; Costa EA; da Cunha LC; Zjawiony JK; Fajemiroye JO J Psychopharmacol; 2019 Jul; 33(7):865-881. PubMed ID: 31192780 [TBL] [Abstract][Full Text] [Related]
34. The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice. Wang Q; Long Y; Hang A; Zan GY; Shu XH; Wang YJ; Liu JG Psychopharmacology (Berl); 2016 Jun; 233(12):2411-8. PubMed ID: 27113225 [TBL] [Abstract][Full Text] [Related]
35. Reversal of Stress-Induced Social Interaction Deficits by Buprenorphine. Browne CA; Falcon E; Robinson SA; Berton O; Lucki I Int J Neuropsychopharmacol; 2018 Feb; 21(2):164-174. PubMed ID: 29020387 [TBL] [Abstract][Full Text] [Related]
36. Effects of co-administration of fluoxetine or tianeptine with metyrapone on immobility time and plasma corticosterone concentration in rats subjected to the forced swim test. Rogóz Z; Skuza G; Leśkiewicz M; Budziszewska B Pharmacol Rep; 2008; 60(6):880-8. PubMed ID: 19211980 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of antidepressant activity of ropinirole coadministered with fluoxetine in acute and chronic behavioral models of depression in rats. Ghorpade S; Tripathi R; Sonawane D; Manjrekar N J Basic Clin Physiol Pharmacol; 2011 Nov; 22(4):109-14. PubMed ID: 22865431 [TBL] [Abstract][Full Text] [Related]
38. Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: A compound devoid of tolerance and withdrawal syndrome. Rosa SG; Pesarico AP; Tagliapietra CF; da Luz SC; Nogueira CW J Psychopharmacol; 2017 Sep; 31(9):1250-1262. PubMed ID: 28857657 [TBL] [Abstract][Full Text] [Related]
39. Sex differences and similarities in depressive- and anxiety-like behaviour in the Wistar-Kyoto rat. Burke NN; Coppinger J; Deaver DR; Roche M; Finn DP; Kelly J Physiol Behav; 2016 Dec; 167():28-34. PubMed ID: 27591842 [TBL] [Abstract][Full Text] [Related]
40. An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence. Rothman RB; Gorelick DA; Heishman SJ; Eichmiller PR; Hill BH; Norbeck J; Liberto JG J Subst Abuse Treat; 2000 Apr; 18(3):277-81. PubMed ID: 10742642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]